4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-005568
SVP Chief Financial Officer sold 1,320 shares at $25.50 ($33,658)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Vairavan Latha · SVP Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sale : show line 1 in the form 10b5-1 | −1,320 | $25.50 | $33,658 | 63,607 | D |
| Open-market sales · 1,320 sh · avg $25.50 · $33,658 | ||||||
Loading xslF345X05/wk-form4_1770251062.xml…